Rajala Ulla, Laakso Mauri, Päivänsalo Markku, Pelkonen Outi, Ruokonen Aimo, Suramo Ilkka, Keinänen-Kiukaanniemi Sirkka
Department of Public Health Science and General Practice, University of Oulu, Aapistie 1, 90220 Oulu, Finland.
Diabetes Res Clin Pract. 2005 Sep;69(3):262-71. doi: 10.1016/j.diabres.2005.01.001.
To evaluate the possible associations of microalbuminuria (MA) and blood pressure (BP) with the ultrasonographic manifestations of carotid, aortic and femoral atherosclerosis in 65-year-old Finns.
Ultrasonographic measurements were performed on 54 diabetic subjects, 97 subjects with impaired glucose tolerance (IGT) and 57 normoglycemic subjects (NGT). Urinary albumin and creatinine concentrations were measured from an early morning spot urine sample, and the urinary albumin-to-creatinine ratio (ACR) of > or = 2.5 mg/mmol in men and > or = 3.5 mg/mmol in women was used as a measure of MA. Hypertension was defined as either a systolic BP of > or = 160 mmHg or a diastolic BP of > or = 95 mmHg or being on antihypertensive medication.
Eighteen subjects were microalbuminuric and 176 subjects normoalbuminuric. MA was associated with diabetes mellitus and high systolic and diastolic BP. The subjects were divided into two groups according to the median total number of carotid, aortic and femoral plaques: > or = 9 versus 0-8 plaques. A high number of plaques were associated with hypertension, male gender, smoking and MA. When the study subjects were stratified according to hypertension, it turned out that MA was associated with a high number of plaques in hypertensive, but not in nonhypertensive subjects. According to the results of logistic regression analysis with a high number of plaques as the dependent variable, the unadjusted OR for smoking was 6.0 (95% CI 2.4-15.3) in hypertensive subjects. Microalbuminuria was of borderline statistical significance (OR 4.5, 95% CI 0.9-22.9). After adjustment for systolic blood pressure and fasting glucose concentration, the OR for microalbuminuria was reduced to 3.3 (95% CI 0.6-18.4).
评估65岁芬兰人微量白蛋白尿(MA)和血压(BP)与颈动脉、主动脉和股动脉粥样硬化超声表现之间的可能关联。
对54名糖尿病患者、97名糖耐量受损(IGT)患者和57名血糖正常(NGT)患者进行超声测量。从清晨随机尿样中测量尿白蛋白和肌酐浓度,男性尿白蛋白与肌酐比值(ACR)≥2.5mg/mmol、女性≥3.5mg/mmol作为MA的衡量标准。高血压定义为收缩压≥160mmHg或舒张压≥95mmHg或正在服用抗高血压药物。
18名受试者有微量白蛋白尿,176名受试者尿白蛋白正常。MA与糖尿病以及高收缩压和舒张压相关。根据颈动脉、主动脉和股动脉斑块总数的中位数将受试者分为两组:≥9个斑块与0 - 8个斑块。大量斑块与高血压、男性、吸烟和MA相关。当根据高血压对研究对象进行分层时,结果显示MA与高血压患者的大量斑块相关,而与非高血压患者无关。以大量斑块作为因变量的逻辑回归分析结果显示,高血压患者中未调整的吸烟优势比(OR)为6.0(95%置信区间2.4 - 15.3)。微量白蛋白尿具有边缘统计学意义(OR 4.5,95%置信区间0.9 - 22.9)。在调整收缩压和空腹血糖浓度后,微量白蛋白尿的OR降至3.3(95%置信区间0.6 - 18.4)。